Transaction · 0001711462-26-000014

Lizzul Paul F.

Lizzul Paul F., CMO, reported a transaction classified as grant at First Tracks Biotherapeutics, Inc. involving 60492.000000 shares for an estimated $0.00. Reported holdings after the transaction were 137651.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

grantSEC transaction code ACMO
TRAXFirst Tracks Biotherapeutics, Inc.
Trade date
Aug 15, 2026
Filing date
Aug 18, 2026
View on SEC Insider profile
Estimated value$0Shares × reported price
Shares traded60.4k$0.00 per share
Holdings after137kDirect
% of reported position tradedUnavailableThis security and ownership context
How reported position traded is calculated

Not calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

TRAX price since this filing

Daily closing prices, with the filing date and available return windows
TRAX · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago -17.5%1w ago +3.3%1d ago +0.4%
Returns since7d +3.8%30d -10.7%90d180d1y

Transaction facts

Stored Form 4 columns with their raw values

Derivative
Type
grant
Code A
Identifier
0001711462-26-000014
Performance Stock Units
Transaction date
Aug 15, 2026
Filed Aug 18, 2026, 08:05 PM · 3d delay
Shares
60,492 sh
$0.00 per share
Estimated value
$0
Computed from shares × price
Holdings after
137,651 sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Derivative Transaction Direct Ownership Large Holdings Increase
Filing-only score

-10 points

Compact filing score computed from stored Form 4 facts. Version v1.

Mixed or weak signal

This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.

How this score is calculated
  • direct_ownership+6 points

    direct_or_indirect_ownership = D

    Direct ownership reports the insider's personal stake.
  • derivative_transaction-16 points

    is_derivative = true

    Derivative exercise rows are less discretionary than open-market purchases.
Read the scoring methodology

Signed filing-only points, not a probability or expected return. Version v1.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

Chief Medical Officer

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    Represents performance-based restricted stock units ("PSUs") that were earned by the Reporting Person upon the achievement of certain performance criteria as certified by the Compensation Committee of…

  2. F2

    Each PSU represents a conditional right to receive one share of the Issuer's Common Stock.

  3. F3

    The PSUs vest and settle over two years; 50% vests on August 15, 2027 and 50% vests on July 1, 2028, subject to the continuing service of the Reporting Person on each vesting date.

Original filing · 0001711462-26-000014
Related transactions

0 other transactions

Same SEC filing
Recent company activity

0 recent txs

TRAX